- Home
- PRTA vs TCI Comparison
PRTA vs TCI Comparison
Compare PRTA & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- TCI
- Stock Information
- Founded
- PRTA 2012
- TCI 1983
- Country
- PRTA Ireland
- TCI United States
- Employees
- PRTA N/A
- TCI N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- TCI Real Estate
- Sector
- PRTA Health Care
- TCI Finance
- Exchange
- PRTA Nasdaq
- TCI Nasdaq
- Market Cap
- PRTA 472.1M
- TCI 357.8M
- IPO Year
- PRTA N/A
- TCI N/A
- Fundamental
- Price
- PRTA $8.20
- TCI $45.60
- Analyst Decision
- PRTA Buy
- TCI
- Analyst Count
- PRTA 10
- TCI 0
- Target Price
- PRTA $14.86
- TCI N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- TCI 1.8K
- Earning Date
- PRTA 08-04-2025
- TCI 08-07-2025
- Dividend Yield
- PRTA N/A
- TCI N/A
- EPS Growth
- PRTA N/A
- TCI 11.20
- EPS
- PRTA N/A
- TCI 0.76
- Revenue
- PRTA $10,341,000.00
- TCI $47,730,000.00
- Revenue This Year
- PRTA N/A
- TCI N/A
- Revenue Next Year
- PRTA $389.77
- TCI N/A
- P/E Ratio
- PRTA N/A
- TCI $61.66
- Revenue Growth
- PRTA N/A
- TCI N/A
- 52 Week Low
- PRTA $4.32
- TCI $25.50
- 52 Week High
- PRTA $22.83
- TCI $48.00
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- TCI 56.33
- Support Level
- PRTA $8.05
- TCI $46.00
- Resistance Level
- PRTA $8.73
- TCI $48.00
- Average True Range (ATR)
- PRTA 0.38
- TCI 0.80
- MACD
- PRTA -0.05
- TCI 0.05
- Stochastic Oscillator
- PRTA 47.62
- TCI 67.90
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.